260 related articles for article (PubMed ID: 10987052)
1. [Prevention of sudden death due to coronary disease].
Spaulding C
Bull Acad Natl Med; 1999; 183(8):1595-603; discussion 1603-5. PubMed ID: 10987052
[TBL] [Abstract][Full Text] [Related]
2. Secondary prevention of sudden cardiac death.
Curnis A; Mascioli G; Bontempi L; Bordonali T; Dei Cas L
Ital Heart J; 2005 Mar; 6(3):216-20. PubMed ID: 15875512
[TBL] [Abstract][Full Text] [Related]
3. Implanted defibrillators and primary prevention of sudden cardiac death: where are we today?
Ray IB; Reddy VY
Int J Cardiol; 2005 Jan; 98(1):15-20. PubMed ID: 15676160
[TBL] [Abstract][Full Text] [Related]
4. Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trial.
Daemen J; Kuck KH; Macaya C; LeGrand V; Vrolix M; Carrie D; Sheiban I; Suttorp MJ; Vranckx P; Rademaker T; Goedhart D; Schuijer M; Wittebols K; Macours N; Stoll HP; Serruys PW;
J Am Coll Cardiol; 2008 Dec; 52(24):1957-67. PubMed ID: 19055986
[TBL] [Abstract][Full Text] [Related]
5. [Ventricular fibrillation in chronic heart disease].
Pleskot M; Parízek P; Hodac M; Haman L; Stásek J; Cervinka P; Tauchman M
Vnitr Lek; 2000 Feb; 46(2):80-6. PubMed ID: 11048528
[TBL] [Abstract][Full Text] [Related]
6. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation.
Holmes DR; Kim LJ; Brooks MM; Kip KE; Schaff HV; Detre KM; Frye RL;
J Thorac Cardiovasc Surg; 2007 Jul; 134(1):38-46, 46.e1. PubMed ID: 17599484
[TBL] [Abstract][Full Text] [Related]
7. Secondary prevention of sudden cardiac death in coronary artery spasm: is implantable cardioverter defibrillator always efficient?
Letsas KP; Filippatos GS; Efremidis M; Sideris A; Kardaras F
Int J Cardiol; 2007 Apr; 117(1):141-3. PubMed ID: 17046086
[TBL] [Abstract][Full Text] [Related]
8. [The problem of sudden death in heart failure].
Delise P; Sciarra L
Ital Heart J; 2005 May; 6 Suppl 1():24S-33S. PubMed ID: 15945297
[TBL] [Abstract][Full Text] [Related]
9. Sudden cardiac death.
Antezano ES; Hong M
J Intensive Care Med; 2003; 18(6):313-29. PubMed ID: 14984660
[TBL] [Abstract][Full Text] [Related]
10. Environmental and psychosocial determinants of sudden death.
Kuller LH; Talbott EO; Robinson C
Circulation; 1987 Jul; 76(1 Pt 2):I177-85. PubMed ID: 3297402
[TBL] [Abstract][Full Text] [Related]
11. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study.
Maradit-Kremers H; Crowson CS; Nicola PJ; Ballman KV; Roger VL; Jacobsen SJ; Gabriel SE
Arthritis Rheum; 2005 Feb; 52(2):402-11. PubMed ID: 15693010
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT).
Borleffs CJ; van Erven L; Schotman M; Boersma E; Kiès P; van der Burg AE; Zeppenfeld K; Bootsma M; van der Wall EE; Bax JJ; Schalij MJ
Eur Heart J; 2009 Jul; 30(13):1621-6. PubMed ID: 19493865
[TBL] [Abstract][Full Text] [Related]
14. [Risk factor grading for prevention of coronary artery disease].
Erbel R; Siffert W; Möhlenkamp S; Schmermund A
Dtsch Med Wochenschr; 2003 Feb; 128(7):330-6. PubMed ID: 12584660
[No Abstract] [Full Text] [Related]
15. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P
J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
[TBL] [Abstract][Full Text] [Related]
16. Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study.
de Bie MK; Lekkerkerker JC; van Dam B; Gaasbeek A; van Buren M; Putter H; van Erven L; Bax JJ; Schalij MJ; Rabelink TJ; Jukema JW
Curr Med Res Opin; 2008 Aug; 24(8):2151-7. PubMed ID: 18561878
[TBL] [Abstract][Full Text] [Related]
17. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
[TBL] [Abstract][Full Text] [Related]
18. Oral nicorandil to reduce cardiac death after coronary revascularization in hemodialysis patients: a randomized trial.
Nishimura M; Tokoro T; Nishida M; Hashimoto T; Kobayashi H; Imai R; Yamazaki S; Okino K; Iwamoto N; Takahashi H; Ono T
Am J Kidney Dis; 2009 Aug; 54(2):307-17. PubMed ID: 19535190
[TBL] [Abstract][Full Text] [Related]
19. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ
Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655
[TBL] [Abstract][Full Text] [Related]
20. Time dependence of defibrillator benefit after coronary revascularization in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML; Wilber DJ; Klein HU;
J Am Coll Cardiol; 2006 May; 47(9):1811-7. PubMed ID: 16682305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
